Sequential designs for phase III clinical trials incorporating treatment selection.
about
Optimizing the data combination rule for seamless phase II/III clinical trials.Stopping rules for phase II studiesCorrecting for bias in the selection and validation of informative diagnostic tests.Longitudinal clinical trials with adaptive choice of follow-up time.Optimizing randomized trial designs to distinguish which subpopulations benefit from treatmentAdaptive design of confirmatory trials: Advances and challenges.Some recommendations for multi-arm multi-stage trialsAdaptive seamless designs: selection and prospective testing of hypotheses.Designing multi-arm multi-stage clinical trials using a risk-benefit criterion for treatment selection.Adaptive designs for comparative effectiveness research trials.Discussion on "A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials" by Elena M. Buzaianu and Pinyuen Chen.Seamless phase II/III designs.Group-sequential methods for adaptive seamless phase II/III clinical trials.Integrated phase II/III clinical trials in oncology: a case study.A comparison of methods for constructing confidence intervals after phase II/III clinical trials.Flexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trial.Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.Simple sequential boundaries for treatment selection in multi-armed randomized clinical trials with a control.A review of statistical designs for improving the efficiency of phase II studies in oncology.Decision-theoretic designs for a series of trials with correlated treatment effects using the Sarmanov multivariate beta-binomial distribution.Estimation in multi-arm two-stage trials with treatment selection and time-to-event endpoint.Alternative designs for clinical trials in rare diseases.A Hybrid Geometric Phase II/III Clinical Trial Design based on Treatment Failure Time and Toxicity.Estimation after subpopulation selection in adaptive seamless trials.Unbiased estimation of odds ratios: combining genomewide association scans with replication studies.A comparison of methods for treatment selection in seamless phase II/III clinical trials incorporating information on short-term endpoints.Confidence intervals for confirmatory adaptive two-stage designs with treatment selection.Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility.Many-to-one comparison after sample size reestimation for trials with multiple treatment arms and treatment selection.Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim.An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints.Statistical issues in drug development.An Adaptive Staggered Dose Design for a Normal Endpoint.Group sequential enrichment design incorporating subgroup selection.On flexibility of adaptive designs and criteria for choosing a good one--a discussion of FDA draft guidance.Dose selection in seamless phase II/III clinical trials based on efficacy and safety.Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology.A conditional error function approach for subgroup selection in adaptive clinical trials.An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information.On sample size determination in multi-armed confirmatory adaptive designs.
P2860
Q30860286-60D4792B-9839-4D4F-8DFD-5D7E13A3F8F3Q34291279-62366326-B6D3-4C96-8B1A-E7BB7AFE2874Q35556604-FB215323-A268-48D7-823A-749EA8192D97Q35779422-4C65A315-9DFD-462C-AC34-3B731BB054A6Q36145026-6DEA7E34-CE8E-4027-91EB-7AA5FBBFEF86Q36264856-01F7E41D-1D0D-494D-A1CD-F0B67535EE96Q36830557-ECB24FD0-D14F-4CC6-B402-2C49167C1667Q37008670-C16E7C8C-E4A3-4A62-B26E-6349D55661C5Q37106434-A049D448-4103-4E15-A8FD-9BB069E5C15DQ37357578-133C0715-6A5E-436C-8C5E-84DC0357BA45Q37771865-659600EA-4887-45C1-965B-5D09CC3FBB82Q37781210-96E363C1-614F-4911-A849-4CCCF4239704Q37868491-F8709476-DE94-4F40-9930-F4D6316950D4Q38062520-4CBD7EDB-64FB-4E08-A796-F74F273CC242Q38156680-F45B382D-094B-49B9-8AAA-3306D24ADD8AQ38280824-1DD44F6A-3016-42E6-AF6A-156D212C0781Q38380750-69A34AC0-06B6-48A2-9ED3-E026A13A819CQ38459886-A2639579-177D-4314-8963-5A4131D097AAQ38510863-EBC4D1DB-857C-4E51-B51C-72B4895565BCQ38660962-73BE2187-9167-4F93-870A-0B24CF6BCF1BQ38726546-E6A31E76-FE89-4D3C-B409-548E38D161F8Q39013156-8E4123A8-7492-4A1C-843D-AD65B143FA3DQ40109131-FC677592-688C-4A7B-907D-FA0A9A57C07CQ41027668-D5F85EB4-8C66-4F2F-B00C-13E6B8F207F6Q41894536-27052FEC-CF82-410C-A72F-44416D961CEEQ42130183-69321D2D-87B5-40C3-A61D-979D30837C53Q42268244-10FCE8D8-491A-4974-877A-0B3428B1F129Q42926272-79DC63A5-6181-4F25-BA29-2B00BFFD05BFQ43832289-83A3A168-E432-4D29-9B4D-9D0A288AA2C8Q44216598-4B9671BE-DE3F-4DE8-A8AE-4569CE64DEF9Q44262116-9808D9E6-0DF2-4807-AC40-AF3396B217BAQ44557252-EFC0FB12-88F4-48EE-AA17-368814BA46AFQ44582568-F5380682-85C0-4A13-B0D5-7B7BF8BE2759Q44588751-69854422-82F3-4184-A851-E3915BCE6DFFQ45328879-10565937-F8B4-4A8B-AFF7-81C4EF558346Q46029341-25D5055F-CE52-4B1F-AEAA-AA77C9CE297CQ46054107-56D3607F-5983-4F53-9DB6-4524294A2708Q46406244-3D2DE29D-5A69-435F-9F58-D5B9B5D68B17Q46743339-2E2316E5-4E8B-4022-9D34-78EB016B6D51Q47379692-4A303AD4-4906-4BA0-B6D3-B1CAB60A85BC
P2860
Sequential designs for phase III clinical trials incorporating treatment selection.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Sequential designs for phase III clinical trials incorporating treatment selection.
@en
Sequential designs for phase III clinical trials incorporating treatment selection.
@nl
type
label
Sequential designs for phase III clinical trials incorporating treatment selection.
@en
Sequential designs for phase III clinical trials incorporating treatment selection.
@nl
prefLabel
Sequential designs for phase III clinical trials incorporating treatment selection.
@en
Sequential designs for phase III clinical trials incorporating treatment selection.
@nl
P356
P1476
Sequential designs for phase III clinical trials incorporating treatment selection.
@en
P2093
Susan Todd
P304
P356
10.1002/SIM.1362
P407
P577
2003-03-01T00:00:00Z